125 related articles for article (PubMed ID: 26160113)
1. Molecular docking design and one-pot expeditious synthesis of novel 2,5-diarylpyrazolo[1,5-a]pyrimidin-7-amines as anti-inflammatory agents.
Aggarwal R; Singh G; Kaushik P; Kaushik D; Paliwal D; Kumar A
Eur J Med Chem; 2015 Aug; 101():326-33. PubMed ID: 26160113
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
Bandgar BP; Adsul LK; Chavan HV; Jalde SS; Shringare SN; Shaikh R; Meshram RJ; Gacche RN; Masand V
Bioorg Med Chem Lett; 2012 Sep; 22(18):5839-44. PubMed ID: 22901385
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular modeling study of 5-trifluoromethyl-Δ²-pyrazoline and isomeric 5/3-trifluoromethylpyrazole derivatives as anti-inflammatory agents.
Aggarwal R; Bansal A; Rozas I; Kelly B; Kaushik P; Kaushik D
Eur J Med Chem; 2013; 70():350-7. PubMed ID: 24177361
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity.
Abouzid K; Bekhit SA
Bioorg Med Chem; 2008 May; 16(10):5547-56. PubMed ID: 18430576
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
8. Ligand-based design, synthesis and primary in vivo screening of pyrrole derivatives as potential tricyclic anti-inflammatory agents.
Bijev A; Yaneva D; Bocheva A; Stoev G
Arzneimittelforschung; 2006; 56(11):753-9. PubMed ID: 17220053
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines.
Almansa C; de Arriba AF; Cavalcanti FL; Gómez LA; Miralles A; Merlos M; García-Rafanell J; Forn J
J Med Chem; 2001 Feb; 44(3):350-61. PubMed ID: 11462976
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation.
Haider S; Alam MS; Hamid H; Shafi S; Nargotra A; Mahajan P; Nazreen S; Kalle AM; Kharbanda C; Ali Y; Alam A; Panda AK
Eur J Med Chem; 2013; 70():579-88. PubMed ID: 24211633
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents.
Khode S; Maddi V; Aragade P; Palkar M; Ronad PK; Mamledesai S; Thippeswamy AH; Satyanarayana D
Eur J Med Chem; 2009 Apr; 44(4):1682-8. PubMed ID: 18986738
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
[TBL] [Abstract][Full Text] [Related]
14. Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.
Manivannan E; Chaturvedi SC
Bioorg Med Chem; 2012 Dec; 20(24):7119-27. PubMed ID: 23146282
[TBL] [Abstract][Full Text] [Related]
15. Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Chandak N; Kumar P; Kaushik P; Varshney P; Sharma C; Kaushik D; Jain S; Aneja KR; Sharma PK
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):476-84. PubMed ID: 23777557
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
Hayashi S; Ueno N; Murase A; Takada J
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):846-67. PubMed ID: 24517373
[TBL] [Abstract][Full Text] [Related]
18. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
[TBL] [Abstract][Full Text] [Related]
19. A novel 1,5-diarylpyrazole derivative exerts its anti-inflammatory effect by inhibition of cyclooxygenase-2 activity as a prodrug.
Yin LL; Li MH; Wang X; Zhang WY
Biol Pharm Bull; 2009 Jun; 32(6):1032-6. PubMed ID: 19483310
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors.
Jiang B; Zeng Y; Li MJ; Xu JY; Zhang YN; Wang QJ; Sun NY; Lu T; Wu XM
Arch Pharm (Weinheim); 2010 Sep; 343(9):500-8. PubMed ID: 20842641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
